We used congenic-resistant mouse strains to answer questions concerning the respective roles of genes coding for major histocompatibility and background genotypes in T (thymus-derived)-B (bone marrow-derived) lymphocyte cooperative responses to hapten-protein conjugates. These studies demonstrate conclusively that the gene or genes present in the H-2 complex control the capacity of antigen-specific T and B cells to effectively interact. These findings led us to postulate that there exists on the B-lymphocyte surface an "acceptor" molecule for the active T-cell product or for the T cell itself.
Recently, we have showvn that histoincompatible carrierprimed thymus-derived (T) lymphocytes of mice fail to provide the required stimulus for the responses of bone marrowderived (B) cells to hapten-carrier conjugates (1) . Thus, under conditions designed to eliminate nonspecific T-cell influences from potential development of an "allogeneic effect" (2) , mixtures of suitably primed T and B lymphocytes from BALB/c and A/J donors, respectively, (or vice versa) failed to cooperate effectively in developing antibody responses either in vivo or in vitro. Since the strains used in these studies, i.e., BALB/c (H-2d) and A/J (H-2a), differed not only at the major histocompatibility locus but for many other polymorphisms as well, we could only speculate that the relevant area of the genome responsible for permitting (or preventing) "physiologic", i.e., antigen-specific, T-B cell cooperative interactions to occur was located in the gene complex coding for the major histocompatibility specificities (1) .
In the present report, we used congenic-resistant mouse strains to answer questions concerning the respective roles of genes coding for major histocompatibility and background genotypes in T-B cell cooperation. These studies demonstrate that genes present in the H-2 complex control the capacity of antigen-specific T and B cells to effectively interact.
MATERIALS AND METHODS
Proteins and Hapten-Carrier Conjugates. Bovine gamma globulin (BGG) was obtained from Pentex Biochemical, Kankakee, Ill. Keyhole limpet hemocyanin (KLH) was purchased from Pacific Biomarine Supply Co., Venice, Calif. The following 2,4-dinitrophenyl (Dnp) conjugates were prepared (3, 4): Dnp32-BGG and Dnp14-KLH. Subscripts refer Abbreviations: T and B lymphocytes, thymus-derived and bone marrow-derived lymphocytes, respectively; Dnp, 2,4-dinitrophenyl; BGG, bovine gamma globulin; KLH, keyhole limpet hemocyanin. * This paper is no. 3 in a series. Paper no. 2 is ref. 1. 2624 to the average number of mol of Dnp per mol of carrier for BGG and to the number of mol per 100,000 molecular weight units for KLH.
The Mice Used in these experiments are listed in Table 1 , which presents the relevant genetic differences between them. A/J, C57BL/10 Sn (B10), and congenic-resistant B1O.A mice were obtained from Jackson Laboratories, Bar Harbor, Me. Congenic-resistant A.By mice were bred in our own animal facilities, and the (A x B1O)F1 hybrid mice were purchased from Dr. Geoffrey Haughton at the University of North Carolina, Chapel Hill, N.C.
Depletion of T Lymphocytes. Preparation of anti-C serum, determination of cytotoxicity of anti-C serum, and anti-C treatment of spleen cells have been described (5 Anti-9-treated 50o f06 Failure of physiologic cooperative interactions to occur between T and B lymphocytes differing at the major histocompatibility locus. The scheme followed is outlined in Fig. 1 Dnp responses to Dnp-BGG, whereas T cells from donor mice differing at H-2, i.e., B10 (Group VI) or A.By (Group VIII), failed to do so irrespective of background genotype.
The final experiment (Fig. 4) (9) (10) (11) (12) (13) . Recently, we have reported results of studies using several approaches designed specifically to answer the question of physiologic cooperative interactions between histoincompatible T and B lymphocytes in humoral immune responses to hapten-carrier conjugates (1, 9) . The experimental schemes were developed to circumvent a complicating allogeneic effect based on the unexpected demonstration of this phenomenon when Dnpprimed B cells were adoptively transferred into heavily irradiated allogeneic recipients (9) . This was accomplished for in vtrivo cell transfer studies in our previous report (1) and also in the experiments presented herein by use of an F1 hybrid host as the recipient of limited numbers of carrier-primed T lymphocytes from one parent (irradiated in situ after transfer) and Dnp-primed B lymphocytes from animals possessing the opposite parental-strain major histocompatibility specificity. The latter cells are depleted of T lymphocytes by treatment with anti-@ serum and complement before transfer to eliminate development of a fatal graft-versus-host reaction in the irradiated F1 recipient. This scheme absolutely avoids the allogeneic effect for several reasons described in detail in our previous reports (1, 9) .
Under these conditions, using BALB/c (H-2d), A/J (H-2)a, and CAF1 (H-2d/H-2a) mouse strains, we previously found that very good T-B cell cooperative interactions occurred between T and B lymphocyte populations derived from syngeneic donors, whereas no cooperative response was obtained when T cells were derived from one parental strain and B cells from the other (1) . These Table 2 . Thus, Dnp-primed B cells from H-2a or H-2b donors developed adoptive secondary anti-Dnp antibody responses in appropriate F1 recipients to Dnp-BGG when mixed with BGG-primed T cells from donor mice that were identical at H-2. This finding was true in combinations where the respective cell populations were identical only at H-2 and exhibited several polymorphisms in their "background" genes.
Conversely, the same B cells that developed responses when mixed with histocompatible T cells failed to respond when the carrier-primed T cells were derived from donors that differed at H-2 irrespective of whether or not the remainder of the genome was identical (Table 2) . Since the strain combinations used in these experiments were all tested on the same day with common pools of donor cells, there is no question of their respective functional capabilities complicating the conclusions drawn from these data.
There are several possible explanations for the failure of physiologic T-B cell cooperation to occur across the major histocompatibility barrier. Certain of these possibilities, which we have dealt with previously (1) and appear to be quite unlikely, include the following:
(i) Failure of transferred T and B cells to migrate to appropriate sites in the lymphoid organs in vivo, and/or rejection of one or the other cell type. These possibilities have been eliminated by use of the F1 host as a neutral environment in which very good cooperative interactions could be obtained between H-2 identical cell mixtures and, moreover, by corroboration of these data in a fully in vitro svstem (1).
(ii) A "block" of some sort to cell-cell interaction by the the cell surface of one or the other of the lymphocyte classes. This was ruled out in our previous studies by experiments demonstrating highly effective cooperation between reciprocal combinations of parental and F1 hybrid T and B lymphocytes (1) . These previous findings demonstrated, moreover (14) .
This reasoning has led us to conclude, therefore, that the genetic restrictions for physiologic cooperation between T and B cells in the immune response concern the physiologic cooperation between these cells. The present studies provide clear evidence that the relevant gene or genes involved belong to the major histocompatibility complex. It is now essential to identify more precisely the genetic region concerned with H-2 primarily involved. In our previous studies, no cooleration occurred with mixtures of T and B cells from BALB/c (H-2d) and A/J (H-2a) donors, respectively (1). These particular strains are identical at SsSlp and the entire D-end of the H-2 complex but possess major differences at the K-end. Many differences exist in the Ir region as well. The present studies have involved strain combinations with major differences in' all regions of the H-2 complex. It will be most important to determine whether differences at the K-end alone, or at either K-or Taking into consideration the above reasoning, the sequence of events surrounding the actual T-B cell interaction could proceed as indicated schematically in Fig. 5 . The antigenactivated T lymphocyte, in close proximity to the appropriate B cell, either engages direct contact at the specific "acceptor" site(s) on the B-cell surface and/or releases active products that have specificity for, and bind to, the specific "acceptor" sites on the B lymphocyte. We believe that the B cell already has antigen bound by its specific surface Ig receptors before the relevant interaction with T cells. As depicted in Fig. 5 , when the reacting T and B cells are syngeneic (A) or semisyngeneic (B), the B cell "acceptor" site can recognize and bind the T-cell product. Note that in semi-syngeneic combinations (B) an additional "acceptor" site with specificity corresponding to the foreign haplotype also exists on the B cell; the reciprocal possibility, i.e., when the T cell bears two different H-2 specificities and the B cell only one, is that the T lymphocyte secretes two molecularly distinct products of which only one binds to the corresponding B cell. In contrast, in the completely histoincompatible combination (Fig. 5C) , the T-cell product secreted after antigen activation is incapable of binding to, and subsequently acting upon, the B cell since the latter lacks an appropriately specific "acceptor" site.
These surface events are followed by the crucial biochemical events concerned with actual triggering of the B lymphocyte.
Similarly, suppressive T-cell regulatory effects might be explained in the context of this scheme if we assume that saturation of T "acceptor" sites on the B cell by active mediator produced in quantitative excess transiently prevents triggering (but does not specifically make tolerant).
One immediate question can be raised about how the in vivo allogeneic effect fits into this framework since the T and B cells involved in this phenomenon are necessarily histoincompatible. The point here is that for the very reason of their histoincompatibility these cells must be brought together into intimate contact, thus fulfilling the seemingly obligate second signal for B-cell triggering. Active T-cell products participating in this type of interaction and perhaps in analogous in vitro phenomena may not be genetically restricted in their range of activity. Lacking this mechanism for recognition of surface antigen differences, isogeneic antigenspecific T and B cells must be brought to close proximity by antigen itselW [either on macrophages, B cells or both (14) ] whereupon the T cell and/or its active product can act on the appropriately exposed B cell "acceptor" site.
